Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
The Journal of Allergy and Clinical Immunology|December 8, 2010
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel, Joshua A Boyce, Amal Assa'ad, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
The Journal of Allergy and Clinical Immunology. Global|September 29, 2023
The SunBEAm birth cohort: Protocol designCorinne Keet, Scott H Sicherer, Supinda Bunyavanich, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Deborah Albright, Sara Anvari, et al.
The New England Journal of Medicine|May 10, 2023
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Sayantani B Sindher, Julie Wang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine|November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy, Brian P Vickery, Andrea Vereda, et al.
Pageof 13